-
How many medical equipment manufacturers are there in the country?
Time of Update: 2022-01-27
According to the statistics of Zhongcheng Digital, as of December 31, 2021, the number of medical device manufacturers in the country reached 28,954, a year-on-year increase of 13. 8% compared with 2
-
"Life-saving medicine" is close to the people, and the monthly average monthly minimum maintenance treatment for ovarian cancer in Guangzhou is less than 800 yuan
Time of Update: 2022-01-27
Sun Yat-Sen University Zhang Bingzhong, director of the Department of Gynecologic Oncology at Sun Yat-sen Memorial Hospital, said in an interview recently that the indications for first-line maintenance therapy of niraparib for ovarian cancer have been included in medical insurance reimbursement, which has benefited more patients .
-
The country talks about speeding up the admission of drugs into the hospital!
Time of Update: 2022-01-27
Through the linkage mechanism, a special pharmacy management meeting will be held within 2 months from the implementation of the new version of the catalogue to adjust and optimize the medication catalogue of the medical institution according to its functional orientation, clinical needs and diagnosis and treatment capabilities, and to provide the country-talked drugs in a timely manner .
-
The second domestic company!
Time of Update: 2022-01-27
A few days ago, the official website of the State Food and Drug Administration showed that Sichuan Proud Times Pharmaceutical's lanthanum carbonate chewable tablets were approved for production in Class 4 imitations .
-
The first filing and registration of medical devices decreased by 20.8% year-on-year, why?
Time of Update: 2022-01-27
Data source: Zhongcheng Digital, statistics as of December 31, 2021 Registration trends From 2017 to 2021, the number of first-time registrations (hereinafter referred to as "initial registrations") of domestic medical device Class II and III products has generally been on the rise, with nearly five The average annual increase is 2332 pieces .
-
The performance appraisal of secondary public hospitals was announced for the first time!
Time of Update: 2022-01-25
Among them, in the column of "rational drug use" of the performance evaluation indicators of secondary public hospitals, "antibacterial drug use intensity (DDDs)", "proportion of essential drug purchase amount", "proportion of the amount of winning drugs in centralized procurement of state-organized drugs", "key monitoring drugs" The proportion of income and the five quantitative indicators of "focus on monitoring the proportion of income of high-value medical consumables" are included in the assessment .
-
Pfizer, Merck have shot!
Time of Update: 2022-01-25
In just two days on January 5th and January 6th, Pfizer and Merck made their moves one after another and reached capital cooperation with BioNTech and Exelead respectively, with a total amount of more than 1 billion US dollars, further consolidating and extending the industrial layout in the frontier field .
-
The overall loss of 130 billion non-public hospital industry can break new business opportunities in the self-help reorganization
Time of Update: 2022-01-25
According to the 2021 Health Statistical Yearbook, the revenue of oncology specialists in the specialty field has won the championship, with an annual surplus of nearly 9 billion yuan; the revenue of specialized hospitals such as cardiovascular, children, and plastic surgery has decreased compared with last year .
-
Hubei Provincial Food and Drug Administration issued the implementation measures for the registration management of licensed pharmacists
Time of Update: 2022-01-25
Provincial and municipal (prefecture) drug regulatory departments shall set up provincial administrators, registration approval administrators, continuing education credit administrators and market supervision administrators, with specific responsibilities as follows: (1) Provincial registration system administrators: responsible for the identity of licensed pharmacists Maintenance of basic card number and registration information, and review of user operation logs in the province .
-
140 OTC drugs sold over 100 million!
Time of Update: 2022-01-25
com, in 2021, there will be 140 OTC products with estimated sales of more than 100 million yuan in urban physical pharmacy terminals in China (excluding double-span, products involving double-span specifications are not included in the statistical scope for the time being), among which Chinese patent medicines accounted for 79, and chemical drugs accounted for 61 .
-
Hubei: Sales of special management drugs, 100% inspection coverage of pharmacies
Time of Update: 2022-01-25
It was learned through the case that from 2020, the staff of a pharmacy in Yanji City sold more than 200 boxes of paracetamol and tramadol tablets and capsules (psychotropic drugs) through face-to-face sales, express delivery, etc.
-
Yangzijiang's exclusive product rises 200%!
Time of Update: 2022-01-25
1. 1 New drugs are coming Figure 1: The market size of Chinese patent medicine stomach medicine in recent years (unit: ten thousand yuan) Source: Minet.
-
Red Sun, Yiling, Taiji and other "rising" sounds sounded!
Time of Update: 2022-01-25
Therefore, in order to break the bottleneck of performance growth and maintain a long-term stable development trend, Chinese medicine companies urgently need to enhance their awareness of innovation, keep up with changes in policies and industry environments, adjust their strategic layout in a timely manner, increase investment in research and development, and make products more diversified .
-
The National Standing Committee deploys centralized procurement to expand area and capacity!
Time of Update: 2022-01-25
. In accordance with the latest requirements of the State Council, in the next step, the state will promote the normalization and institutionalization of centralized and volume-based procurement, accelerate the expansion of coverage, and continue to reduce drug prices to benefit patients: First, focus on chronic diseases and common diseases, and continue to promote national-level drug collection Purchasing, all localities carry out provincial or inter-provincial alliance procurement of drugs outside the national centralized procurement .
-
3074 hospitals participated!
Time of Update: 2022-01-25
From this, it can be seen that the level of electronic medical records of secondary public hospitals is obviously not as good as that of tertiary hospitals, which will inevitably affect the smoothness of the national examination process .
-
In 2022, "10,000 pharmacies" will appear in batches, and chain giants will do this!
Time of Update: 2022-01-25
Almost all major projects during the year were promoted by ordinary people: 680 million yuan was spent to acquire 100% equity of Chifeng Renchuan, Inner Mongolia, and 287 stores were acquired in one bite; the acquisition of 51% equity of Hebei Huatuo Pharmacy cost 1.
-
In 2021, the national medical device priority approval will drop by 12.2% year-on-year. What is the reason?
Time of Update: 2022-01-25
Data source: Zhongcheng Digital (formerly Zhongcheng Medical Equipment), Medical Device Innovation Network Provincial and City Ranking From the perspective of the distribution of products in provinces and cities, Tianjin has the largest number of products entering the Class II priority approval channel, with 66 products ranking first Ranked second with 55 cases in Chongqing, and third with 44 cases in Anhui Province .
-
The first TOP10 generic drug companies are released!
Time of Update: 2022-01-25
Focusing on the leading enterprise of "big infusion" in the advantageous field Kelun Pharmaceutical, more than 40 generic drugs have been approved for production in the past three years, and injections account for "half of the country", of which 6 are first imitation.
-
Pharmaceutical stocks evaporate 1.2 trillion yuan in one year, Jingdong Health, Hengrui lead the decline
Time of Update: 2022-01-25
On January 1, 2021, the total market value of A-share listed traditional Chinese medicine companies was 878 billion yuan, and a year later, the number increased to 1,179.
-
The hypoglycemic drug market is turbulent again, and Fosun Pharma's 55 million yuan is lost
Time of Update: 2022-01-25
At the same time, Hengrui Medicine also issued an announcement stating that the Class 1 chemical drug Proline Henggliflozin Tablets was approved for marketing, which is also the first domestically-made innovative SGLT2 inhibitor approved in China .
